Logo image of XENE

XENON PHARMACEUTICALS INC (XENE) Stock Analyst Ratings

NASDAQ:XENE - Nasdaq - CA98420N1050 - Common Stock - Currency: USD

31.33  -0.16 (-0.51%)

After market: 31.33 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to XENE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 55.97. This target is 78.65% above the current price.
XENE was analyzed by 25 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about XENE.
In the previous month the buy percentage consensus was at a similar level.
XENE was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
XENE Historical Analyst RatingsXENE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -103 -93 -83 -73 -63 -53 -43 -33 -23 -13 -3 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 31.3342.4256.1055.9768.25 - 35.40% 79.06% 78.65% 117.84%
XENE Current Analyst RatingXENE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-05-14 Evercore ISI Group Initiate Outperform
2025-05-13 Chardan Capital Maintains Buy -> Buy
2025-05-13 Needham Maintains Buy -> Buy
2025-05-13 RBC Capital Maintains Outperform -> Outperform
2025-05-13 Wells Fargo Maintains Overweight -> Overweight
2025-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-07 Chardan Capital Initiate Buy
2025-04-17 Goldman Sachs Maintains Buy -> Buy
2025-02-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-11 Deutsche Bank Initiate Buy
2024-12-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-13 Needham Reiterate Buy -> Buy
2024-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Outperform
2024-10-01 HC Wainwright & Co. Initiate Buy
2024-09-03 RBC Capital Reiterate Outperform -> Outperform
2024-08-12 Needham Maintains Buy -> Buy
2024-08-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-09 Wedbush Maintains Outperform -> Outperform
2024-06-18 RBC Capital Reiterate Outperform -> Outperform
2024-05-10 Needham Maintains Buy -> Buy
2024-05-10 Wedbush Maintains Outperform -> Outperform
2024-05-10 Citigroup Maintains Buy -> Buy
2024-04-12 Needham Reiterate Buy -> Buy
2024-04-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-01 Needham Maintains Buy -> Buy
2024-03-01 RBC Capital Maintains Outperform -> Outperform
2024-03-01 Wedbush Maintains Outperform -> Outperform
2024-01-04 Citigroup Initiate Buy
2024-01-02 B of A Securities Maintains Buy -> Buy